The single-cell profiling of T-cell repertoires across a number of gliomas identified an NK-cell like subset of cytotoxic T cells marked by CD161 with increased PDCD1 activity and the impaired killing of tumour cells, highlighting the bidirectional interplay between tumour and immune cells [93]. The gene discussed is KLRB1; the disease is neoplasm.